MedTrace Logo

Anxiety and Depression in COPD; Prevalence, Detection and Prognosis

NCT04427579 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2020-06-11

No results posted yet for this study

Summary

The current cohort study of 300 stable COPD patients aims to assess the following topics:

* The prevalence of anxiety and depressive disorders in patients with COPD
* The screening properties of Hospital Anxiety and Depression Scale in patients with COPD
* The prognostic influence by anxiety or depressive symptoms and anxiety or depressive disorder.
* whether characterization of 1) affective aspects of dyspnea symptoms or 2) persistent styles of thinking (worry or rumination) and metacognitions that drive these may improve the current recommendation of screening for anxiety and depression in COPD in relation to its clinical relevance on functional status and three year outcome

Conditions

  • COPD
  • Anxiety Disorders
  • Depressive Disorder

Sponsors & Collaborators

  • University of Oslo

    collaborator OTHER

  • LHL Hospital Gardermoen

    collaborator UNKNOWN

  • Priory Hospital Altrincham

    collaborator UNKNOWN

  • University Hospital, Akershus

    lead OTHER

Principal Investigators

  • Gunnar Einvik, PhD · University Hospital, Akershus

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-15
Primary Completion
2023-12-31
Completion
2025-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04427579 on ClinicalTrials.gov